Large
accelerated filer
|
o
|
Accelerated
filer
|
o
|
|
Non-accelerated
filer
|
o
|
Smaller
reporting company
|
R
|
MATERIAL
TECHNOLOGIES, INC.
|
||||
(A
Development Stage Company)
|
||||
CONDENSED
CONSOLIDATED BALANCE SHEET
|
||||
June
30,
|
||||
2008
|
||||
(Unaudited)
|
||||
ASSETS
|
||||
Current
assets:
|
||||
Cash
and cash equivalents
|
$ | 530,045 | ||
Inventories
|
148,964 | |||
Prepaid
expenses and other current assets
|
62,941 | |||
Total
current assets
|
741,950 | |||
Property
and equipment, net
|
89,632 | |||
Intangible
assets, net
|
2,302 | |||
Deposit
|
2,348 | |||
$ | 836,232 |
MATERIAL
TECHNOLOGIES, INC.
|
||||
(A
Development Stage Company)
|
||||
CONDENSED
CONSOLIDATED BALANCE SHEET - Continued
|
||||
June
30,
|
||||
2008
|
||||
(Unaudited)
|
||||
(Restated)
|
||||
LIABILITIES
AND STOCKHOLDERS' DEFICIT
|
||||
Current
liabilities:
|
||||
Accounts
payable and accrued expenses
|
$ | 470,017 | ||
Current
portion of research and development sponsorship payable
|
25,000 | |||
Notes
payable
|
67,573 | |||
Total
current liabilities
|
562,590 | |||
Accrued
legal settlement
|
250,000 | |||
Research
and development sponsorship payable, net of current
portion
|
784,100 | |||
Convertible
debentures and accrued interest payable, net of discount
|
270,973 | |||
Notes
payable, long-term
|
222,110 | |||
Derivative
and warrant liabilities
|
75,760,425 | |||
77,287,608 | ||||
Total
liabilities
|
77,850,198 | |||
Minority
interest in consolidated subsidiary
|
825 | |||
Commitments
and contingencies
|
||||
Stockholders'
deficit:
|
||||
Class
A preferred stock, $0.001 par value, liquidation
preference
|
||||
of $720
per share; 350,000 shares authorized; 337 shares issued
|
||||
and
outstanding as of June 30, 2008
|
- | |||
Class
B preferred stock, $0.001 par value, liquidation preference
of
|
||||
$10,000
per share; 15 shares authorized; none issued
and
|
||||
outstanding
as of June 30, 2008
|
- | |||
Class
C preferred stock, $0.001 par value, liquidation preference
of
|
||||
$0.001
per share; 25,000,000 shares authorized; 1,517 shares
issued
|
||||
and
outstanding as of June 30,2008
|
1 | |||
Class
D preferred stock, $0.001 par value, liquidation preference
of
|
||||
$0.001
per share; 20,000,000 shares authorized; none shares
issued
|
||||
and
outstanding as of June 30,2008
|
- | |||
Class
E convertible preferred stock, $0.001 par value, no
liquidation
|
||||
preference;
60,000 shares authorized; 53,700 shares issued and
|
||||
outstanding
as of June 30,2008
|
54 | |||
Class
A Common Stock, $0.001 par value, 600,000,000 shares
|
||||
authorized;
168,499 shares issued and 149,330 shares outstanding
|
||||
at
June 30,2008
|
149 | |||
Class
B Common Stock, $0.001 par value, 600,000 shares
authorized,
|
||||
issued
and outstanding as of June 30,2008
|
600 | |||
Warrants
subscribed
|
10,000 | |||
Additional
paid-in-capital
|
326,904,859 | |||
Deficit
accumulated during the development stage
|
(403,834,055 | ) | ||
Treasury
stock ( 293 shares at cost at June 30, 2008)
|
(96,399 | ) | ||
Total
stockholders' deficit
|
(77,014,791 | ) | ||
$ | 836,232 |
MATERIAL
TECHNOLOGIES, INC.
|
||||||||||||||||||||
(A
Development Stage Company)
|
||||||||||||||||||||
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
||||||||||||||||||||
From
October 21, 1983
|
||||||||||||||||||||
For
the Three Months Ended
|
For
the Six Months Ended
|
(Inception)
|
||||||||||||||||||
June
30,
|
June
30,
|
through
|
||||||||||||||||||
2007
|
2008
|
2007
|
2008
|
June
30, 2008
|
||||||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||||||||
(Restated)
|
(Restated)
|
(Restated)
|
||||||||||||||||||
Revenues:
|
||||||||||||||||||||
Research
and development
|
$ | - | $ | - | $ | - | $ | - | $ | 5,392,085 | ||||||||||
Revenue
from bridge testing
|
22,778 | 66,745 | 1,090 | 319,714 | ||||||||||||||||
Other
|
- | - | - | - | 274,125 | |||||||||||||||
Total
revenues
|
22,778 | - | 66,745 | 1,090 | 5,985,924 | |||||||||||||||
Costs
and expenses:
|
||||||||||||||||||||
Research
and development
|
3,294,575 | 150,847 | 3,512,076 | 309,840 | 20,872,829 | |||||||||||||||
General
and administrative
|
41,016,474 | 5,517,443 | 62,475,638 | 25,845,768 | 329,341,009 | |||||||||||||||
Modification
of research and development sponsorship agreement
|
- | - | - | - | 5,963,120 | |||||||||||||||
Loss
on settlement of lawsuits
|
- | - | - | - | 1,267,244 | |||||||||||||||
Total
costs and expenses
|
44,311,049 | 5,668,290 | 65,987,714 | 26,155,608 | 357,444,202 | |||||||||||||||
Loss
from operations
|
(44,288,271 | ) | (5,668,290 | ) | (65,920,969 | ) | (26,154,518 | ) | (351,458,278 | ) | ||||||||||
Other
income (expense):
|
||||||||||||||||||||
Loss
on modification of convertible debt
|
- | (964,730 | ) | - | (964,730 | ) | (378,485 | ) | ||||||||||||
Loss
on subcription receivables
|
(1,368,555 | ) | ||||||||||||||||||
Interest
expense
|
(612,416 | ) | (606,028 | ) | (1,590,651 | ) | (977,019 | ) | (12,717,212 | ) | ||||||||||
Other-than-temporary
impairment of marketable securities available for
sale
|
- | (9,785,947 | ) | |||||||||||||||||
Net
unrealized and realized loss of marketable securities
|
(8,556,211 | ) | (8,556,219 | ) | (8 | ) | (9,398,226 | ) | ||||||||||||
Change
in fair value of investments derivative liability
|
- | - | - | - | (210,953 | ) | ||||||||||||||
Change
in fair value of derivative and warrant liabilities
|
6,942,597 | (71,103,676 | ) | 22,920,017 | (62,544,101 | ) | (18,957,012 | ) | ||||||||||||
Interest
income
|
12,594 | 3,080 | 15,966 | 15,523 | 482,405 | |||||||||||||||
Other
|
- | - | - | - | (25,992 | ) | ||||||||||||||
Other
income (expense), net
|
(2,213,436 | ) | (72,671,354 | ) | 12,789,113 | (64,470,335 | ) | (52,359,977 | ) | |||||||||||
Loss
before provision for income taxes
|
(46,501,707 | ) | (78,339,644 | ) | (53,131,856 | ) | (90,624,853 | ) | (403,818,255 | ) | ||||||||||
Provision
for income taxes
|
- | - | (800 | ) | (800 | ) | (15,800 | ) | ||||||||||||
Net
loss
|
$ | (46,501,707 | ) | $ | (78,339,644 | ) | $ | (53,132,656 | ) | $ | (90,625,653 | ) | $ | (403,834,055 | ) | |||||
Per
share data:
|
||||||||||||||||||||
Basic
and diluted net loss per share
|
$ | (448.38 | ) | $ | (500.20 | ) | $ | (580.45 | ) | $ | (614.04 | ) | ||||||||
Weighted
average Class A common shares outstanding - basic and
diluted
|
103,710 | 156,617 | 91,538 | 147,589 |
MATERIAL
TECHNOLOGIES, INC.
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
||||||||||||
From
October 21, 1983
|
||||||||||||
For
the Six Months Ended
|
(Inception)
|
|||||||||||
June
30,
|
through
|
|||||||||||
2007
|
2008
|
June
30, 2008
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
(Restated)
|
(Restated)
|
|||||||||||
Cash
flows from operating activities:
|
||||||||||||
Net
loss
|
$ | (53,132,656 | ) | $ | (90,625,653 | ) | $ | (403,834,055 | ) | |||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||||||
Loss
on modification of convertible debt
|
- | 964,730 | 378,485 | |||||||||
Impairment
loss
|
19,255,875 | - | 21,391,528 | |||||||||
Loss
on charge off of subscription receivables
|
- | 1,368,555 | ||||||||||
Issuance
of common stock for services
|
15,558,944 | 3,625,200 | 210,110,040 | |||||||||
Increase
in debt for services and fees
|
- | 1,100,000 | 5,556,625 | |||||||||
Officer's
stock based compensation
|
30,000,000 | 19,885,333 | 86,460,675 | |||||||||
Issuance
of common stock for modification of research and development
sponsorship agreement
|
- | 7,738,400 | ||||||||||
Change
in fair value of derivative and warrant liabilities
|
(41,351,889 | ) | ||||||||||
Net
realized and unrealized loss on marketable securities
|
8,556,200 | 7,895,705 | ||||||||||
Other-than-temporary
impairment of marketable securities available for
sale
|
- | 9,785,946 | ||||||||||
Legal
fees incurred for note payable
|
1,456,142 | |||||||||||
Accrued
interest expense added to principal
|
156,901 | 135,816 | 1,630,821 | |||||||||
Amortization
of discount on convertible debentures
|
1,431,081 | 824,072 | 10,930,350 | |||||||||
Change
in fair value of investments derivative liability
|
(22,920,017 | ) | 62,544,101 | 65,767,423 | ||||||||
Accrued
interest income added to principal
|
(5,428 | ) | 25,433 | (279,565 | ) | |||||||
Depreciation
and amortization
|
1,951 | 10,621 | 238,405 | |||||||||
Other
non-cash adjustments
|
- | (114,730 | ) | |||||||||
(Increase)
decrease in trade receivables
|
91,787 | 108,661 | (50,328 | ) | ||||||||
(Increase)
decrease in inventories
|
- | (86,748 | ) | (148,964 | ) | |||||||
(Increase)
decrease in prepaid expenses and other current
assets
|
(22,500 | ) | (17,257 | ) | 225,316 | |||||||
Increase
in deposits
|
- | (2,348 | ) | |||||||||
(Decrease)
increase in accounts payable and
accrued expenses
|
(141,766 | ) | (130,968 | ) | 2,377,927 | |||||||
Net
cash used in operating activities
|
(1,169,628 | ) | (1,636,659 | ) | (12,469,536 | ) | ||||||
Cash
flows from investing activities:
|
||||||||||||
Proceeds
from the sale of marketable securities
|
95,006 | 300,000 | 3,758,476 | |||||||||
Purchase
of marketable securities
|
(302,038 | ) | - | (2,206,379 | ) | |||||||
Investment
in certificate of deposits and commerical paper
|
(700,177 | ) | (565,000 | ) | (1,965,000 | ) | ||||||
Maturities
of certificate of deposits and commercial paper
|
- | 1,565,000 | 1,965,000 | |||||||||
Payment
received on officer loans
|
- | 3,803 | 880,058 | |||||||||
Funds
advanced to officers
|
- | - | (549,379 | ) | ||||||||
Proceeds
received in acquisition of consolidated subsidiaries
|
600,000 | |||||||||||
Purchase
of property and equipment
|
- | (17,167 | ) | (373,419 | ) | |||||||
Investment
in joint ventures
|
- | - | (102,069 | ) | ||||||||
Proceeds
from foreclosure
|
- | - | 44,450 | |||||||||
Proceeds
from the sale of property and equipment
|
- | - | 19,250 | |||||||||
Payment
for license agreement
|
- | - | (6,250 | ) | ||||||||
Net
cash provided by (used in) investing activities
|
(907,209 | ) | 1,286,636 | 2,064,738 |
MATERIAL
TECHNOLOGIES, INC.
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
CONSOLIDATED
STATEMENTS OF CASH FLOWS - Continued
|
||||||||||||
From
October 21, 1983
|
||||||||||||
For
the Six Months Ended
|
(Inception)
|
|||||||||||
June
30,
|
through
|
|||||||||||
2007
|
2008
|
June
30, 2008
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
(Restated)
|
(Restated)
|
|||||||||||
Cash
flow from financing activities:
|
||||||||||||
Proceeds
from the sale of common stock and warrants
|
$ | 2,850,000 | $ | 18,624 | $ | 9,464,577 | ||||||
Proceeds
from convertible debentures and other notes payable
|
200,000 | 55,000 | 2,102,766 | |||||||||
Proceeds
from the sale of preferred stock
|
100,000 | - | 473,005 | |||||||||
Costs
incurred in offerings
|
(773,779 | ) | - | (1,130,932 | ) | |||||||
Capital
contributions
|
- | - | 301,068 | |||||||||
Purchase
of treasury stock
|
(17,381 | ) | (3,266 | ) | (170,641 | ) | ||||||
Principal
reduction on notes payable
|
(26,671 | ) | (100,000 | ) | ||||||||
Payment
on proposed reorganization
|
- | - | (5,000 | ) | ||||||||
Net
cash provided by (used in) financing activities
|
2,332,169 | 70,358 | 10,934,843 | |||||||||
Net
change in cash and cash equivalents
|
255,332 | (279,665 | ) | 530,045 | ||||||||
Cash
and cash equivalents, beginning of period
|
129,296 | 809,710 | - | |||||||||
Cash
and cash equivalents, end of period
|
$ | 384,628 | $ | 530,045 | $ | 530,045 | ||||||
Supplemental
disclosure of cash flow information:
|
||||||||||||
Interest
paid during the period
|
$ | 2,669 | $ | 281 | ||||||||
Income
taxes paid during the period
|
$ | 800 | $ | 800 |
Supplemental
disclosures of non-cash investing and financing
activities:
|
||||||||
2008
|
||||||||
During
the six months ended June 30, 2008, the Company issued 4,230 shares of its
Class A common shares in
|
||||||||
the
conversion of $491,132 of convertible debt.
|
||||||||
During
the six months ended June 30, 2008, the Company issued 13,207 shares of
its Class A common stock
|
||||||||
for
consulting services valued at $3,668,400.
|
||||||||
During
the six months ended June 30, 2008, the Company issued 378 shares of its
Class A common stock
|
||||||||
pursuant
to the anti-dilution provisions of a settlement
agreement.
|
||||||||
During
the six months ended June 30, 2008. a former employee returned 450 shares
of the Company's Class A
|
||||||||
common
stock to treasury which were subsequently cancelled.
|
||||||||
During
the six months ended June 30, 2008. the Company's president returned
30,000 shares of the Company's
|
||||||||
Class
A common stock to treasury which were subsequently
cancelled.
|
||||||||
During
the six months ended June 30, 2008, the Company issued 34,500 shares of
its Class A common stock
|
||||||||
in
consideration of the exercise of cashless warrants. The Company accrued
derivative liability in connection with the
|
||||||||
granting
of the warrants, which had a balance of $1,151,900 on the date of
exercise. The liability balance was credited to equity.
|
||||||||
During
the six months ended June 30, 2008, the Company issued 78 shares of its
Class A common stock for $18,624.
|
||||||||
During
the six months ended June 30, 2008, the Company issued 1,040 shares of the
Company's common stock
|
||||||||
was
issued through the conversion of 1,300 shares of the Company's Class E
preferred shares.
|
||||||||
During
the six months ended June 30, 2008, the Company contingent obligation to
Mr. Beck under a settlement agreement
|
||||||||
was
reduced to $0, therefore the Company reduced its legal settlement
liability by the remaining accrued provision of
$230,000,
|
||||||||
which
was credited to equity.
|
||||||||
During
the six months ended June 30, 2008, the Company obtained $55,000 through
the issuance of convertible debt. In connection
|
||||||||
with
this debt, the Company recognized a beneficial conversion feature of
$28,140 that was credited to
equity.
|
During
the six months ended June 30, 2008, the Company recognized compensation
expense of $8,800 on the grant of
|
||||||||
options
to its employees and officers for the purchase of 800.000 shares of Class
A common stock. In addition, during the six months
|
||||||||
the
Company granted options to its President for the purchase of 400,000,000
shares of its Class A common stock and granted
options
|
||||||||
to
a consultant to purchase 15,390,546 shares of its Class A common stock.
The Company recognized a derivative liability of
$6,400,000
|
||||||||
on
the granting of these options.
|
||||||||
2007
|
||||||||
During
the six months ended June 30, 2007, the Company issued 2,839 shares of its
Class A common stock
|
||||||||
for
consulting services valued at $13,158,944.
|
||||||||
During
the six months ended June 30, 2007, the Company received $1,000,000 in
consideration of issuing 2,500 units.
|
||||||||
Each
unit consists of one share of the Company's Class A common stock and a
warrant to purchase
|
||||||||
one
share of the Company's common stock at a price of $.60 per share. In
connection with the private offering
|
||||||||
the
Company paid $239,065 in fees and issued warrants to purchase 2,118 shares
of the Company's
|
||||||||
common
stock at a price of $1.20 per share.
|
||||||||
During
the six months ended June 30, 2007, the Company issued 50,000 shares its
Class E Series convertible
|
||||||||
preferred
stock in exchange for receiving all of the outstanding shares of Stress
Analysis Technologies, Inc. ("SATI").
|
||||||||
The
Company valued the acquisition at $19,355,875 of which $19,255,875 was
allocated to the acquired license.
|
||||||||
Durng
the six months ended June 30, 2007, the Company deemed the license to be
impaired and charged of the
|
||||||||
$19,255,875
to operation. In connection with this transaction, the Company issued an
additional 5,000 preferred
|
||||||||
shares
valued at $2,400,000 for fees in connection with the purchase. The
$2,400,000 was charged to operations.
|
||||||||
During
the six months ended June 30, 2007, the Company issued 10,800
shares in escrow pursuant to an agreement it has with
|
||||||||
with
its convertible debenture holders. During 2007, 5,800 shares of Class A
common stock was issued to certain
|
||||||||
debenture
holders in the conversion of $580,000 of indebtedness. In
addition, for the redemption of 1,000 shares by certain
debenture
|
||||||||
holders,
the balance due on the debentures was increased by
$600,000.
|
||||||||
During
the six months ended June 30, 2007, the Company received 50 shares of
prior issued common stock
|
||||||||
which
was subsequently cancelled.
|
For
the Three Months Ended
|
||||||||||||
June
30, 2008
|
||||||||||||
As
Originally Stated
|
Adjustments
|
As
Corrected
|
||||||||||
Revenues:
|
||||||||||||
Research
and development
|
$ | - | $ | - | $ | - | ||||||
Revenue
from bridge testing
|
- | - | ||||||||||
Other
|
- | - |
Total
revenues
|
- | - | - | |||||||||||||
Costs
and expenses:
|
||||||||||||||||
Research
and development
|
150,847 | 150,847 | ||||||||||||||
General
and administrative
|
5,517,443 | 5,517,443 | ||||||||||||||
Total
costs and expenses
|
5,668,290 | - | 5,668,290 | |||||||||||||
Loss
from operations
|
(5,668,290 | ) | - | (5,668,290 | ) | |||||||||||
Other
income (expense):
|
||||||||||||||||
Interest
expense
|
(397,973 | ) | 1 | ) | (208,055 | ) | (606,028 | ) | ||||||||
Loss
on modification of convertible debt
|
- | 2 | ) | (964,730 | ) | (964,730 | ) | |||||||||
Change
in fair value of derivative liabilities
|
(6,036,711 | ) | 3 | ) | (65,066,965 | ) | (71,103,676 | ) | ||||||||
Interest
income
|
3,080 | 3,080 | ||||||||||||||
Other
expense, net
|
(6,431,604 | ) | (66,239,750 | ) | (72,671,354 | ) | ||||||||||
Loss
before provision for income taxes
|
(12,099,894 | ) | (66,239,750 | ) | (78,339,644 | ) | ||||||||||
Provision
for income taxes
|
- | - | - | |||||||||||||
Net
loss
|
$ | (12,099,894 | ) | $ | (66,239,750 | ) | $ | (78,339,644 | ) | |||||||
Per
share data:
|
||||||||||||||||
Basic
and diluted net loss per share
|
$ | (77.26 | ) | $ | (422.94 | ) | $ | (500.20 | ) | |||||||
|
||||||||||||||||
Weighted average
Class A common shares outstanding - basic and
diluted
|
156,617 | 156,617 | 156,617 |
1) To
record additional interest of $16,597 on the increased balance of debt
and
amortization of increased discount totalling
$191,458.
|
2)
To record loss on modification of convertible debt.
|
3) To
expense increase in derivative liability due to the reduction in conversion price of
convertible debt and granting of warrants to purchase 35M shares of common
stock.
|
For
the Six Months Ended
|
||||||||||||||||
June
30, 2008
|
||||||||||||||||
As
Originally Stated
|
Adjustments
|
As
Corrected
|
||||||||||||||
Revenues:
|
||||||||||||||||
Research
and development
|
$ | - | - | $ | - | |||||||||||
Revenue
from bridge testing
|
1,090 | - | 1,090 | |||||||||||||
Other
|
- | - | - | |||||||||||||
Total
revenues
|
1,090 | - | 1,090 | |||||||||||||
Costs
and expenses:
|
||||||||||||||||
Research
and development
|
309,840 | 309,840 | ||||||||||||||
General
and administrative
|
25,845,768 | 25,845,768 | ||||||||||||||
Total
costs and expenses
|
26,155,608 | - | 26,155,608 | |||||||||||||
Loss
from operations
|
(26,154,518 | ) | - | (26,154,518 | ) | |||||||||||
Other
income (expense):
|
||||||||||||||||
Interest
expense
|
(768,964 | ) | 1 | ) | (208,055 | ) | (977,019 | ) | ||||||||
Loss
on modification of convertible debt
|
- | 2 | ) | (964,730 | ) | (964,730 | ) | |||||||||
Change
in fair value of derivative liabilities
|
||||||||||||||||
Interest
income
|
- | |||||||||||||||
Other
expense, net
|
- | - | ||||||||||||||
Net
unrealized and realized loss of marketable securities
|
(8 | ) | (8 | ) | ||||||||||||
Change
in fair value of derivative liabilities
|
2,522,864 | 3 | ) | (65,066,965 | ) | (62,544,101 | ) | |||||||||
Interest
income
|
15,523 | 15,523 | ||||||||||||||
1,769,415 | (66,239,750 | ) | (64,470,335 | ) | ||||||||||||
Loss
before provision for income taxes
|
(24,385,103 | ) | (66,239,750 | ) | (90,624,853 | ) | ||||||||||
Provision
for income taxes
|
(800 | ) | - | (800 | ) | |||||||||||
Net
loss
|
$ | (28,200,501 | ) | $ | (66,239,750 | ) | $ | (90,625,653 | ) | |||||||
Per
share data:
|
||||||||||||||||
Basic
and diluted net loss per share
|
$ | (0.31 | ) | $ | (723.63 | ) | $ | (990.04 | ) | |||||||
|
||||||||||||||||
Weighted
average Class A common shares outstanding - basic and
diluted
|
91,538 | 91,538 | 91,538 |
1) To
record additional interest of $16,597 on the increased balance of debt and
amortization
of increased discount totaling
$191,458.
|
2)
To record loss on modification of convertible debt.
|
3) To
expense increase in derivative liability due to the reduction in
conversion price of convertible debt and
granting of warrants to purchase 35M shares of common
stock.
|
June
30, 2008
|
||||||||||||||||
As
Originally Stated
|
Adjustments
|
As
Corrected
|
||||||||||||||
Current
liabilities:
|
||||||||||||||||
Accounts
payable and accrued expenses
|
$ | 470,017 | $ | - | $ | 470,017 | ||||||||||
Current
portion of research and development
sponsorship payable
|
25,000 | - | 25,000 | |||||||||||||
Notes
payable
|
67,573 | - | 67,573 | |||||||||||||
Convertible
debentures and accrued interest payable, net of
discount
|
3,323,466 | 1 | ) | (3,289,571 | ) | - | ||||||||||
2 | ) | (33,895 | ) | |||||||||||||
Total
current liabilities
|
3,886,056 | (3,323,466 | ) | 562,590 | ||||||||||||
- | ||||||||||||||||
Accrued
legal settlement
|
250,000 | - | 250,000 | |||||||||||||
Research
and development sponsorship payable, net of current
portion
|
784,100 | - | 784,100 | |||||||||||||
Convertible
debentures and accrued interest payable, net of
discount
|
29,024 | 3 | ) | 4,254,301 | 270,973 | |||||||||||
3 | ) | (4,254,301 | ) | |||||||||||||
4 | ) | 241,949 | ||||||||||||||
Notes
payable, long-term
|
222,110 | - | 222,110 | |||||||||||||
Derivative
and warrant liabilities
|
6,439,158 | 1 | ) | 4,254,301 | 75,760,425 | |||||||||||
5 | ) | 65,066,966 | ||||||||||||||
7,724,392 | 69,563,216 | 77,287,608 |
Total
liabilities
|
11,610,448 | 66,239,750 | 77,850,198 | |||||||||||||
Minority
interest in consolidated subsidiary
|
825 | 825 | ||||||||||||||
Commitments
and contingencies
|
||||||||||||||||
Stockholders'
deficit:
|
||||||||||||||||
Preferred
Stock
|
55 | 55 | ||||||||||||||
Class
A Common Stock,
|
149,330 | 6 | ) | (149,181 | ) | 149 | ||||||||||
Class
B Common Stock,
|
600 | - | 600 | |||||||||||||
Warrants
subscribed
|
10,000 | - | 10,000 | |||||||||||||
Additional
paid-in-capital
|
326,755,678 | 6 | ) | 149,181 | 326,904,859 | |||||||||||
Deficit
accumulated during the development stage
|
(337,594,305 | ) | 1 | (964,730 | ) | (403,834,055 | ) | |||||||||
2 | ) | 33,895 | ||||||||||||||
4 | ) | (241,949 | ) | |||||||||||||
5 | ) | (65,066,966 | ) | |||||||||||||
Treasury
stock
|
(96,399 | ) | - | (96,399 | ) | |||||||||||
- | ||||||||||||||||
Total
stockholders' deficit
|
(10,775,041 | ) | (66,239,750 | ) | (77,014,791 | ) | ||||||||||
- | ||||||||||||||||
$ | 836,232 | $ | - | $ | 836,232 |
1) To record gain
on extinquishmment of
balance of convertible debt prior to the modification of
the debt and to record derivative warrant liability on the issuance
of 35M
warrants.
|
2)
To adjust accrued interest on note balance at June 16,
2008.
|
3) To record
balance of new convertible debt and related discount based upon the terms of the June
16, 2008 agreement.
|
4)
To record accrued interest on the modified balance of convertible debt and
amortization modified discount.
|
5)
To adjust derivative warrant liability at June 30, 2008 to fair
value.
|
6)
To adjust common stock for October 2008 1000:1 reverse stock
split.
|
Finished
goods
|
$ | 142,964 |
Office
and computer equipment
|
$ | 27,645 | ||
Manufacturing
equipment
|
230,522 | |||
258,167 | ||||
Less
accumulated depreciation
|
(168,535 | ) | ||
$ | 89,632 |
Period
of
Amortization
|
|||||
Patent
costs
|
17
years
|
$ | 28,494 | ||
License
agreement (see Note 7)
|
17
years
|
6,250 | |||
Website
|
5
years
|
5,200 | |||
39,944 | |||||
Less
accumulated amortization
|
(37,642 | ) | |||
$ | 2,302 |
2008
|
$ | 538 | ||
2009
|
$ | 1,076 | ||
2010
|
$ | 688 |
August
2, 2009
|
$ | 30,000 | ||
August
2, 2010
|
$ | 30,000 | ||
August
2, 2011 and each year thereafter
|
$ | 50,000 |
January
29, 2010
|
$ | 21,000 | ||
January
29, 2011
|
$ | 32,000 | ||
January
29, 2012
|
$ | 42,000 |
January
1, 2009
|
$ | 10,000 | ||
January
1, 2010
|
$ | 20,000 | ||
January
1, 2011 and each year thereafter
|
$ | 30,000 |
|
·
|
If
an Event of Default occurs under the Notes, and, if such Event of Default
is curable, such Event of Default continues for a period of 30 days
without being cured, then the 10% interest rate set forth in the Notes
will be increased to a Default Interest Rate of 18% per annum, and the
total balance of principal and accrued interest of the debentures shall
bear interest at the Default Interest Rate from the date of the occurrence
of such Event of Default
|
|
·
|
In
addition, the entry of any judgment against the Company in excess of
$150,000, regardless of where, how, to whom or under what agreement such
liability arises, shall be an Event of Default under the Debentures,
unless (i) the Company pays such judgment within 60 days, or (ii) the
Company duly files an appeal of such judgment and execution of such
judgment is stayed. Finally, the entry of any order or judgment
in favor of any judgment creditor or other creditor attaching the assets
of the Company shall be an Event of Default under these
debentures. The conversion price of the debentures shall not be
at any time more than $0.10 per share, regardless of any combination of
shares of the Common Stock of the Company by reverse split or
otherwise.
|
|
·
|
If an Event of
Default occurs which is not cured within its
applicable cure period, if it is curable,
the conversion price of these debentures after such cure period has
expired shall be reduced to half of the pre-Event of Default conversion
price. For clarification, if the conversion price before an
Event of Default were the lesser of 50% of market price or $0.10, then the
new conversion price would be the lesser of 25% of market price or
$0.05.
|
|
·
|
The
Company shall not issue any shares of its Class A Common Stock without a
legend stating that such shares may not be sold, transferred, pledged,
assigned or alienated for a period of at least one year following the date
of the issuance of such certificate, other than shares issued to or with
the written consent of the Holder. Notwithstanding the
foregoing, this provision shall not apply to (i) any shares issued to
purchasers in a financing where the Company receives net proceeds of at
least Five Hundred Thousand Dollars ($500,000) and the shares are sold for
not less than fifty percent (50%) of the closing price of the Company’s
common stock reported as of the closing date of such financing, and (ii)
any shares issued in connection with an acquisition of assets by the
Company where (a) the Company provides to the Holder a fairness opinion as
to the value of the acquired assets, and (b) the Company receives assets
that are worth at least fifty percent (50%) of the closing price per share
of the Company’s common stock as of the closing date of the
acquisition.
|
|
·
|
The
Company shall not enter into any agreement pursuant to which any party
other than the Holder has pre-emptive rights, the right to receive shares
of any class of securities of the Company for no additional consideration,
the right to receive a set, pre-determined percentage of the outstanding
shares of the Company for any period of time, or any other similar right
that has the effect of maintaining a set percentage of the issued and/or
outstanding shares of any class or classes of the capital stock of the
Company.
|
|
·
|
The
Company shall not enter into any agreement giving another party
anti-dilution protection unless (1) all shares received pursuant to such
provision are subject to a two-year lock-up from the date of issuance, and
(2) all such shares received are subject to a “dribble-out,” following the
two-year lock-up, restricting their sale to not more than 1/20th
of 5% of the previous month’s total trading volume in any single trading
day.
|
|
·
|
The
Company will not file any Registration Statement on Form S-8 nor issue any
shares registered on Form S-8, exclusive of shares currently registered on
Form S-8. However, when the total capital in the Company’s cash
account drops below $500,000, the Company may issue up to $30,000 worth of
securities registered on Form S-8, valued at the market price of the
common stock on the date of issuance, per month,
non-cumulative. Any issuance of S-8 shares will be supported by
an opinion of the Company’s counsel that such issuance complies in all
respects with federal
securities
|
|
laws. This
opinion will be provided to the legal representative of the Holder upon
request. Further, the Company will ensure that every entity or
individual that receives S-8 shares will be subject to a “dribble-out”
restricting their sale to not more than 1/20th
of 2% of the previous month’s total trading volume in any single trading
day, non-cumulative. The above described dribble-out is not an
aggregate sale restriction for all entities and individuals receiving S-8
shares;
|
|
·
|
The
Company has informed the Holder that it is considering completing a
one-for-one-thousand reverse split of its common stock, as described in an
Information Statement filed by the Company on or about April 25,
2008. The Company acknowledges that the conversion price of the
Debenture shall not be effected by any such reverse split, and that after
giving effect to such reverse split, the conversion price shall remain the
lesser of (i) 50% of the averaged ten closing prices for the Company’s
Common Stock for the ten trading days immediately preceding the Conversion
Date or (ii) $0.10. The Holder consents to this
action. The parties acknowledge that the Company is not
obligated to complete this reverse-split, or any reverse
split.
|
|
·
|
The
shareholder lockup provisions will not apply to up to any shares held by
Mr. Robert Bernstein, and sold by him personally in a bona-fide sale to an
unrelated, unaffiliated third party; provided, that (i) the number of
shares sold shall not exceed Two Million Five Hundred Thousand Dollars
($2,500,000) worth of stock, calculated based on the number of shares sold
multiplied by the closing price of the stock on the date such shares are
sold (if a market trade) or transferred on the books of the transfer agent
(if a private transfer). Once Two Million Five Hundred Thousand
Dollars ($2,500,000) worth of stock has been sold as calculated above, the
lockup on whatever remains of the shares owned by Mr. Bernstein (if
any) goes back into effect. In this regard, if Mr. Bernstein
sells any of his shares without legend, then he may only sell up to 1/20th
of 5% of the previous month’s total trading volume in any single trading
day, and he may not sell more than 1% of the issued and outstanding shares
of Matech during any 90 day period. Further, if Mr. Bernstein sells
any of his shares, he must have such shares transferred on the books of
the transfer agent within five business days of the sale. Mr.
Bernstein shall comply with all reporting requirements under Section 16 of
the Securities Exchange Act of 1934, as
amended.
|
|
Fatigue
Fuse
|
EFS
|
Server
Array
System
|
X-Ray
Diffraction Method
|
Nondestructive
evaluation and stimulate industrial innovation
|
|||||||||||||||
Variety
Investments, Ltd.
|
5.00 | % | - | - | - | - | ||||||||||||||
University
of Pennsylvania (see Note 7)
|
||||||||||||||||||||
Net
sales of licensed products
|
- | 7.00 | % | - | - | - | ||||||||||||||
Net
sales of services
|
- | 2.50 | % | - | - | - | ||||||||||||||
NCAT
(see Note 7)
|
||||||||||||||||||||
Net
sales of licensed products
|
- | - | 3.50 | % | - | - | ||||||||||||||
Sublicensing
income
|
- | - | 25.00 | % | - | - | ||||||||||||||
ISIS (see
Note 7)
|
||||||||||||||||||||
Net
sales of licensed products
|
- | - | - | 2.5 | % | - | ||||||||||||||
Sublicensing
income
|
- | - | - | 25.00 | % | - | ||||||||||||||
ISURF
(see Note 7)
|
||||||||||||||||||||
Net
sales of licensed products
|
- | - | - | - | 3.0 | % | ||||||||||||||
Sublicensing
income
|
- | - | - | - | 25.00 | % | ||||||||||||||
Shareholder
|
1.00 | % | 0.50 | % | - | - | - |
Issued
shares
|
168,499 | |||
Less
shares held in escrow:
|
||||
Shares
issued to the Company and held in escrow
|
(3,357 | ) | ||
Shares
held in escrow pursuant to agreement debenture holders
|
(8,000 | ) | ||
Contingent
shares held related to the Beck settlement for antidilution
purposes (see Note 10)
|
(7,806 | ) | ||
Other
|
(6 | ) | ||
(19,169 | ) | |||
Outstanding
shares (including shares committed)
|
149,330 |
Weighed
|
||||||||
Options/
|
Average
|
|||||||
Warrants
|
Exercise
|
|||||||
Outstanding
|
Price
|
|||||||
Balance
– December 31, 2007
|
35,131,667 | $ | 0.003 | |||||
Granted
|
456,190,546 | $ | 0.007 | |||||
Exercised
|
(34,500,000 | ) | $ | (0.001 | ) | |||
Forfeited
|
(13,333 | ) | $ | (0.001 | ) | |||
Balance
– June 30, 2008
|
456,808,880 | $ | 0.007 |
June 30, 2008 | ||||||||||||||||
Fair Value Measurements* | ||||||||||||||||
Level
1
|
Level
2
|
Level
3
|
Fair
Value
|
|||||||||||||
Assets | ||||||||||||||||
Cash | $ | 530,045 | $ | - | $ | - | $ | 530,045 | ||||||||
Liabilities | ||||||||||||||||
Accounts payable and accrued expenses | $ | 470,017 | $ | - | $ | - | $ | 470,017 | ||||||||
Derivative and warrant liability | $ | - | $ | 75,760,425 | $ | - | $ | 75,760,425 |
|
Derivative
and
|
||||
|
Warrant Liability | ||||
Balance
– January 1, 2008
|
$ | 10,113,923 | |||
Total
realized and unrealized losses
|
|||||
Included
in operations
|
62,544,101 | ||||
Liability accrued on issuance of | |||||
convertible
long-term debt
|
4,254,301 | ||||
Liability credited to equity on | |||||
exercise
of 34,500 warrants
|
(1,151,900 | ) | |||
Balance
– June 30, 2008
|
$ | 75,760,425 |
Six
months
Ended
June
30, 2008
|
Six
months
Ended
June
30, 2007
|
Percentage
Change
|
||||||||||
Revenue | $ | 1,090 | $ | 66,745 | (98.36 | )% | ||||||
Research and development costs | $ | 309,840 | $ | 3,512,076 | (91.17 | )% | ||||||
General and administrative expenses | $ | 25,845,768 | $ | 62,475,638 | (58.63 | )% | ||||||
Loss from operations | $ | (26,154,518 | ) | $ | (65,920,969 | ) | (60.32 | )% |
Six
months
Ended
June
30, 2008
|
Six
months
Ended
June
30, 2007
|
|||||||
Consulting services | $ | 4,790,293 | $ | 12,177,839 | ||||
Officer’s salary | 251,000 | 125,000 | ||||||
Officer’s stock based compensation | 19,887,533 | 30,000,000 | ||||||
Secretarial salaries | 65,497 | 44,576 | ||||||
Office expense | 36,865 | 36,453 | ||||||
Professional fees | 444,936 | 535,782 | ||||||
Rent | 16,197 | 15,258 | ||||||
Marketing & Promo | 111,214 | 138,786 | ||||||
Impairment loss | -- | 19,255,875 | ||||||
Payroll taxes | 35,008 | 17,461 | ||||||
Travel | 67,830 | 69,614 | ||||||
Insurance | 33,777 | 16,155 | ||||||
Telephone | 10,617 | 11,977 |
Six
months
Ended
June
30, 2008
|
Six
months
Ended
June
30, 2007
|
Percentage
Change
|
||||||||||
Interest expense | $ | (977,019 | ) | $ | (1,590,651 | ) | (38.58 | )% | ||||
Loss on modification of convertible debt | (964,730 | ) | -- | 100.00 | % | |||||||
Net unrealized and realized loss of marketable securities | $ | (8 | ) | $ | (8,556,219 | ) | (100.00 | )% | ||||
Change in fair value of derivative and warrant liabilities | $ | (62,544,101 | ) | $ | 22,920,017 | (372.88 | )% | |||||
Interest income | $ | 15,523 | $ | 15,966 | (2.77 | )% | ||||||
Provision for income taxes | (800 | ) | (800 | ) | 0 | % | ||||||
Net loss | $ | (90,625,653 | ) | $ | (53,132,656 | ) | (70,56 | )% |
June
30, 2008
|
June
30, 2007
|
|||||||
Cash | $ | 530,045 | $ | 384,628 | ||||
Marketing securities - trading | $ | -- | $ | 342,169 | ||||
Investment in certificate of deposits | $ | -- | $ | 704,800 | ||||
Accounts receivable | $ | -- | $ | 24,920 | ||||
Inventories | $ | 148,964 | $ | -- | ||||
Prepaid expenses and other | $ | 62,941 | $ | 32,323 | ||||
Total current assets | $ | 741,950 | $ | 1,488,840 | ||||
Total assets | $ | 836,232 | $ | 2,139,025 | ||||
Total current liabilities | $ | 3,886,056 | $ | 445,467 | ||||
Total liabilities | $ | 11,610,448 | $ | 3,941,680 |
10.1 *
|
License
Agreement with Fatigue Solutions Corp., dated May 21,
2008
|
10.2 *
|
Business
Agreement with The India-America Technology Agency, dated May 25,
2008
|
10.3 *
|
Indemnification
Agreement with Marybeth Miceli Newton, dated June 5,
2008
|
10.4 *
|
Teaming
Agreement with e-RADLIK, Inc., dated June 6, 2008
|
10.5 *
|
Convertible
Debenture issued to Kreuzfeld, Ltd., dated July 31,
2008
|
10.6 *
|
Security
Agreement with Kreuzfeld, Ltd., dated July 31, 2008
|
10.7 *
|
Financing
Escrow Agreement with Continental Advisors, SA and Corporate Legal
Services, LLP, dated July 31, 2008
|
10.8 *
|
Registration
Rights Agreement with Kreuzfeld, Ltd., dated August 6,
2008
|
Dated:
August 3, 2009
|
/s/ Robert M. Bernstein | ||
By: |
Robert M.
Bernstein
|
||
Its: | President, Chief Executive Officer, | ||
and Chief Financial Officer (Principal | |||
Executive Officer, Principal Financial | |||
Officer and Principal Accounting Officer) |